Renal IRI is a leading cause of AKI in several disease states; currently there are several methods to measure renal perfusion in the clinic, but all suffer under specific drawbacks. Here we present a pilot study using the hyperpolarized perfusion marker α-trideuteromethyl[15N]glutamine in a 40 min unilateral ischemia reperfusion rat model. A reduction of 51% in perfusion was observed in the animal. We therefore believe that α-trideuteromethyl[15N]glutamine is a highly promising molecule in renal perfusion studies.
This abstract and the presentation materials are available to members only; a login is required.